Tradename | Company | Number | Date | Products |
---|---|---|---|---|
TPN | International Minerals | N-008378 DISCN | 1982-01-01 | 1 products |
Brand Name | Status | Last Update |
---|---|---|
adult infuvite multiple vitamins | New Drug Application | 2019-05-14 |
adult infuvite multiple vitamins for infusion pharmacy bulk | New Drug Application | 2013-01-01 |
animi-3 | unapproved drug other | 2013-02-06 |
animi-3 with vitamin d | unapproved drug other | 2011-05-23 |
b-plex 100 | unapproved drug other | 2020-12-04 |
bacmin | unapproved drug other | 2014-05-02 |
bal-care dha | unapproved drug other | 2012-05-01 |
bal-care dha essential | unapproved drug other | 2012-05-01 |
bonjesta | New Drug Application | 2023-07-07 |
bp vit 3 | unapproved drug other | 2023-10-11 |
Indication | Ontology | MeSH | ICD-10 |
---|---|---|---|
seizures | HP_0007359 | D012640 | G40.4 |
vitamin b 6 deficiency | — | D026681 | E53.1 |
Code | Description |
---|---|
J3415 | Injection, pyridoxine hcl, 100 mg |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Tuberculosis | D014376 | EFO_0000774 | A15-A19 | 2 | 9 | 10 | 3 | 7 | 29 |
Hiv infections | D015658 | EFO_0000764 | B20 | 1 | 2 | 8 | 3 | 10 | 24 |
Anemia | D000740 | HP_0001903 | D64.9 | — | 2 | 6 | 1 | 13 | 21 |
Obesity | D009765 | EFO_0001073 | E66.9 | 1 | — | — | 2 | 14 | 17 |
Vitamin d deficiency | D014808 | EFO_0003762 | E55 | 1 | 2 | 1 | 2 | 9 | 13 |
Cardiovascular diseases | D002318 | HP_0001626 | — | 1 | 4 | 1 | 4 | 3 | 12 |
Covid-19 | D000086382 | — | U07.1 | 2 | 1 | 3 | 1 | 6 | 12 |
Pregnancy | D011247 | EFO_0002950 | Z33.1 | 1 | — | 3 | 3 | 5 | 12 |
Aging | D000375 | GO_0007568 | R41.81 | — | — | — | 2 | 9 | 11 |
Iron-deficiency anemia | D018798 | HP_0001891 | D50 | — | — | 2 | 2 | 6 | 10 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Healthy volunteers/patients | — | — | — | 6 | 4 | 1 | — | 12 | 23 |
Malnutrition | D044342 | EFO_0008572 | E40-E46 | — | 2 | 1 | — | 11 | 13 |
Breast neoplasms | D001943 | EFO_0003869 | C50 | 1 | 4 | 3 | — | 4 | 12 |
Hiv | D006678 | — | O98.7 | 2 | 3 | 3 | — | 3 | 10 |
Colorectal neoplasms | D015179 | — | — | 1 | 3 | 3 | — | 2 | 7 |
Hyperhomocysteinemia | D020138 | — | — | — | 1 | 2 | — | 4 | 7 |
Diarrhea | D003967 | HP_0002014 | R19.7 | — | — | 1 | — | 5 | 6 |
Prostatic neoplasms | D011471 | — | C61 | — | — | 1 | — | 4 | 5 |
Oxidative stress | D018384 | EFO_1001905 | — | — | 2 | 1 | — | 3 | 5 |
Myocardial ischemia | D017202 | EFO_1001375 | I20-I25 | — | 2 | 1 | — | 1 | 4 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Hypertension | D006973 | EFO_0000537 | I10 | 1 | 1 | — | — | 4 | 6 |
Type 1 diabetes mellitus | D003922 | EFO_0001359 | E10 | — | 1 | — | — | 4 | 5 |
Autism spectrum disorder | D000067877 | HP_0000729 | F84.0 | — | 2 | — | — | 3 | 5 |
Chronic pain | D059350 | HP_0012532 | — | — | 1 | — | — | 4 | 5 |
Lymphoma | D008223 | — | C85.9 | 3 | 4 | — | — | — | 4 |
Chronic fatigue syndrome | D015673 | EFO_0004540 | G93.31 | — | 2 | — | — | 2 | 4 |
Traumatic brain injuries | D000070642 | — | S06 | — | 2 | — | — | 2 | 4 |
Chronic obstructive pulmonary disease | D029424 | EFO_0000341 | J44.9 | — | 1 | — | — | 2 | 3 |
Psoriasis | D011565 | EFO_0000676 | L40 | 1 | 1 | — | — | 1 | 2 |
Respiratory distress syndrome | D012128 | EFO_1000637 | J80 | 1 | 1 | — | — | 1 | 2 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Depression | D003863 | — | F33.9 | 1 | — | — | — | 3 | 4 |
Hip fractures | D006620 | EFO_0003964 | S72.00 | 1 | — | — | — | 2 | 3 |
Birth weight | D001724 | EFO_0004344 | — | 1 | — | — | — | 1 | 2 |
Heart rate | D006339 | EFO_0004326 | — | 1 | — | — | — | — | 1 |
Biological availability | D001682 | — | — | 1 | — | — | — | — | 1 |
Triple negative breast neoplasms | D064726 | — | — | 1 | — | — | — | — | 1 |
Myeloid leukemia acute | D015470 | — | C92.0 | 1 | — | — | — | — | 1 |
Bcr-abl positive chronic myelogenous leukemia | D015464 | EFO_0000340 | — | 1 | — | — | — | — | 1 |
Burns | D002056 | — | T30.0 | 1 | — | — | — | — | 1 |
Prostatic intraepithelial neoplasia | D019048 | — | N42.31 | 1 | — | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Weight loss | D015431 | HP_0001824 | — | — | — | — | — | 6 | 6 |
Iron deficiencies | D000090463 | — | E61.1 | — | — | — | — | 5 | 5 |
Anxiety | D001007 | EFO_0005230 | F41.1 | — | — | — | — | 4 | 4 |
Growth disorders | D006130 | — | — | — | — | — | — | 4 | 4 |
Cognitive dysfunction | D060825 | HP_0001268 | G31.84 | — | — | — | — | 4 | 4 |
Diet therapy | D004035 | — | — | — | — | — | — | 3 | 3 |
Aggression | D000374 | EFO_0003015 | — | — | — | — | — | 3 | 3 |
Hypercholesterolemia | D006937 | HP_0003124 | — | — | — | — | — | 3 | 3 |
Metabolism | D008660 | GO_0008152 | — | — | — | — | — | 3 | 3 |
Healthy diet | D000072001 | — | — | — | — | — | — | 3 | 3 |
Drug common name | Pyridoxine |
INN | pyridoxine |
Description | Pyridoxine is a hydroxymethylpyridine with hydroxymethyl groups at positions 4 and 5, a hydroxy group at position 3 and a methyl group at position 2. The 4-methanol form of vitamin B6, it is converted intoto pyridoxal phosphate which is a coenzyme for synthesis of amino acids, neurotransmitters, sphingolipids and aminolevulinic acid. It has a role as a cofactor, a human metabolite, a Saccharomyces cerevisiae metabolite, an Escherichia coli metabolite and a mouse metabolite. It is a monohydroxypyridine, a vitamin B6, a member of methylpyridines and a hydroxymethylpyridine. |
Classification | Small molecule |
Drug class | — |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | Cc1ncc(CO)c(CO)c1O |
PDB | — |
CAS-ID | 65-23-6 |
RxCUI | — |
ChEMBL ID | CHEMBL1364 |
ChEBI ID | 16709 |
PubChem CID | 1054 |
DrugBank | DB00165 |
UNII ID | KV2JZ1BI6Z (ChemIDplus, GSRS) |